By: Shelley Wood, Eric J. Topol
Skepticism, business imperatives, and changing demographics are muddying the clear-blue waters By Shelley Wood and Eric J. Topol
Shelley Wood is a former Editor-in-Chief at TCTMD and the Editorial Director at the Cardiovascular Research Foundation (CRF). With a focus on interventional cardiology and medical journalism, she has significantly contributed to the field, transforming TCTMD into a respected and award-winning resource recognized by cardiologists worldwide. Shelley has been featured in prominent publications such as The Globe and Mail, Medscape, and STAT News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Shelley Wood's focus is on medical research, particularly in the field of cardiology and heart disease. Her coverage attributes suggest a strong reliance on data-driven content.
To effectively reach out to Shelley, consider providing pitches that highlight new and significant findings from medical research or clinical trials within the field of cardiology. Emphasize insights that are supported by robust data and offer potential advancements in pharmaceutical treatments for heart-related conditions.
Given her strong emphasis on citing data, ensure that any information provided is backed by reliable sources and studies. It may also be beneficial to provide access to experts who can interpret complex scientific findings related to cardiology in a clear and accessible manner.
This information evolves through artificial intelligence and human feedback. Improve this profile .